Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 7Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Aspirin Cardio

02 1AspirinTM Cardio

PharmaCompass

01

Brand Name : Aspirin Cardio

Acetylsalicylic Acid

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Aspirin Cardio

arrow
2024 ACI Convention
Not Confirmed

Acetylsalicylic Acid

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 773

2019 Revenue in Millions : 700

Growth (%) : 10

blank

02

Brand Name : Aspirin Cardio

Acetylsalicylic Acid

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Aspirin Cardio

arrow
2024 ACI Convention
Not Confirmed

Acetylsalicylic Acid

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 746

2020 Revenue in Millions : 773

Growth (%) : 6

blank

03

Brand Name : Aspirin Cardio

Acetylsalicylic Acid

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Aspirin Cardio

arrow
2024 ACI Convention
Not Confirmed

Acetylsalicylic Acid

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 827

2021 Revenue in Millions : 746

Growth (%) : 11

blank

04

Brand Name : Aspirin Cardio

Acetylsalicylic Acid

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Aspirin Cardio

arrow
2024 ACI Convention
Not Confirmed

Acetylsalicylic Acid

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 679

2022 Revenue in Millions : 827

Growth (%) : -21

blank

05

Brand Name : Aspirin Cardio

Acetylsalicylic Acid

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Aspirin Cardio

arrow
2024 ACI Convention
Not Confirmed

Acetylsalicylic Acid

Main Therapeutic Indication : Cardiovascular

Currency : USD

2015 Revenue in Millions : 535

2014 Revenue in Millions : 576

Growth (%) : 8%

blank

06

Brand Name : AspirinTM Cardio

Acetylsalicylic Acid

arrow
2024 ACI Convention
Not Confirmed

Brand Name : AspirinTM Cardio

arrow
2024 ACI Convention
Not Confirmed

Acetylsalicylic Acid

Main Therapeutic Indication : Cardiovascular

Currency : USD

2014 Revenue in Millions : 7.50%

2013 Revenue in Millions :

Growth (%) :

blank

07

Brand Name : Aspirin Cardio

Acetylsalicylic Acid

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Aspirin Cardio

arrow
2024 ACI Convention
Not Confirmed

Acetylsalicylic Acid

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2017 Revenue in Millions : 720

2016 Revenue in Millions : 667

Growth (%) : 8

blank

08

Brand Name : Aspirin Cardio

Acetylsalicylic Acid

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Aspirin Cardio

arrow
2024 ACI Convention
Not Confirmed

Acetylsalicylic Acid

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2016 Revenue in Millions : 570

2015 Revenue in Millions : 555

Growth (%) : 3

blank

09

Brand Name : Aspirin Cardio

Acetylsalicylic Acid

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Aspirin Cardio

arrow
2024 ACI Convention
Not Confirmed

Acetylsalicylic Acid

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2018 Revenue in Millions : 629

2017 Revenue in Millions : 657

Growth (%) : -4%

blank

10

Brand Name : Aspirin Cardio

Acetylsalicylic Acid

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Aspirin Cardio

arrow
2024 ACI Convention
Not Confirmed

Acetylsalicylic Acid

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2019 Revenue in Millions : 631

2018 Revenue in Millions : 607

Growth (%) : 4

blank